Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

Cited In for PubMed (Select 19136055)

1.

Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study.

Zerbo O, Yoshida C, Grether JK, Van de Water J, Ashwood P, Delorenze GN, Hansen RL, Kharrazi M, Croen LA.

J Neuroinflammation. 2014 Jun 20;11:113. doi: 10.1186/1742-2094-11-113.

2.

Increased anti-phospholipid antibodies in autism spectrum disorders.

Careaga M, Hansen RL, Hertz-Piccotto I, Van de Water J, Ashwood P.

Mediators Inflamm. 2013;2013:935608. doi: 10.1155/2013/935608. Epub 2013 Sep 23.

3.

Air pollution and newly diagnostic autism spectrum disorders: a population-based cohort study in Taiwan.

Jung CR, Lin YT, Hwang BF.

PLoS One. 2013 Sep 25;8(9):e75510. doi: 10.1371/journal.pone.0075510. eCollection 2013.

4.

Traffic-related air pollution, particulate matter, and autism.

Volk HE, Lurmann F, Penfold B, Hertz-Picciotto I, McConnell R.

JAMA Psychiatry. 2013 Jan;70(1):71-7. doi: 10.1001/jamapsychiatry.2013.266.

5.

Structural, genetic, and functional signatures of disordered neuro-immunological development in autism spectrum disorder.

Saxena V, Ramdas S, Ochoa CR, Wallace D, Bhide P, Kohane I.

PLoS One. 2012;7(12):e48835. doi: 10.1371/journal.pone.0048835. Epub 2012 Dec 4.

6.

Modeling autism: a systems biology approach.

Randolph-Gips M, Srinivasan P.

J Clin Bioinforma. 2012 Oct 8;2(1):17. doi: 10.1186/2043-9113-2-17.

7.

Activating killer-cell immunoglobulin-like receptors (KIR) and their cognate HLA ligands are significantly increased in autism.

Torres AR, Westover JB, Gibbons C, Johnson RC, Ward DC.

Brain Behav Immun. 2012 Oct;26(7):1122-7. doi: 10.1016/j.bbi.2012.07.014. Epub 2012 Aug 3.

8.

Decreased levels of total immunoglobulin in children with autism are not a result of B cell dysfunction.

Heuer LS, Rose M, Ashwood P, Van de Water J.

J Neuroimmunol. 2012 Oct 15;251(1-2):94-102. doi: 10.1016/j.jneuroim.2012.07.001. Epub 2012 Jul 31.

9.

Identification of autoimmune gene signatures in autism.

Jung JY, Kohane IS, Wall DP.

Transl Psychiatry. 2011 Dec 13;1:e63. doi: 10.1038/tp.2011.62.

10.

Levels of soluble platelet endothelial cell adhesion molecule-1 and P-selectin are decreased in children with autism spectrum disorder.

Onore CE, Nordahl CW, Young GS, Van de Water JA, Rogers SJ, Ashwood P.

Biol Psychiatry. 2012 Dec 15;72(12):1020-5. doi: 10.1016/j.biopsych.2012.05.004. Epub 2012 Jun 19.

11.

Low serum IgA and increased expression of CD23 on B lymphocytes in peripheral blood in children with regressive autism aged 3-6 years old.

Wasilewska J, Kaczmarski M, Stasiak-Barmuta A, Tobolczyk J, Kowalewska E.

Arch Med Sci. 2012 May 9;8(2):324-31. doi: 10.5114/aoms.2012.28561.

12.

Consensus paper: pathological role of the cerebellum in autism.

Fatemi SH, Aldinger KA, Ashwood P, Bauman ML, Blaha CD, Blatt GJ, Chauhan A, Chauhan V, Dager SR, Dickson PE, Estes AM, Goldowitz D, Heck DH, Kemper TL, King BH, Martin LA, Millen KJ, Mittleman G, Mosconi MW, Persico AM, Sweeney JA, Webb SJ, Welsh JP.

Cerebellum. 2012 Sep;11(3):777-807. doi: 10.1007/s12311-012-0355-9. Review.

13.

The potential role of probiotics in the management of childhood autism spectrum disorders.

Critchfield JW, van Hemert S, Ash M, Mulder L, Ashwood P.

Gastroenterol Res Pract. 2011;2011:161358. doi: 10.1155/2011/161358. Epub 2011 Oct 26.

14.

The role of immune dysfunction in the pathophysiology of autism.

Onore C, Careaga M, Ashwood P.

Brain Behav Immun. 2012 Mar;26(3):383-92. doi: 10.1016/j.bbi.2011.08.007. Epub 2011 Aug 28. Review.

15.

In search of cellular immunophenotypes in the blood of children with autism.

Ashwood P, Corbett BA, Kantor A, Schulman H, Van de Water J, Amaral DG.

PLoS One. 2011 May 4;6(5):e19299. doi: 10.1371/journal.pone.0019299.

16.

Residential proximity to freeways and autism in the CHARGE study.

Volk HE, Hertz-Picciotto I, Delwiche L, Lurmann F, McConnell R.

Environ Health Perspect. 2011 Jun;119(6):873-7. doi: 10.1289/ehp.1002835. Epub 2010 Dec 16.

17.

Autoantibodies to cerebellum in children with autism associate with behavior.

Goines P, Haapanen L, Boyce R, Duncanson P, Braunschweig D, Delwiche L, Hansen R, Hertz-Picciotto I, Ashwood P, Van de Water J.

Brain Behav Immun. 2011 Mar;25(3):514-23. doi: 10.1016/j.bbi.2010.11.017. Epub 2010 Dec 4.

18.

Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders.

Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J.

J Neuroimmunol. 2011 Mar;232(1-2):196-9. doi: 10.1016/j.jneuroim.2010.10.025. Epub 2010 Nov 20.

19.

Altered T cell responses in children with autism.

Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah IN, Van de Water J.

Brain Behav Immun. 2011 Jul;25(5):840-9. doi: 10.1016/j.bbi.2010.09.002. Epub 2010 Sep 15.

20.

Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.

Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van de Water J.

Brain Behav Immun. 2011 Jan;25(1):40-5. doi: 10.1016/j.bbi.2010.08.003. Epub 2010 Aug 10.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk